Search Results - "McNeal, John E."

Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens by Wise, Alphaeus M, Stamey, Thomas A, McNeal, John E, Clayton, John L

“…Objectives. To examine the histologic details of small, independent cancers compared with the largest (index) tumor and their impact on prostate-specific…”
Get full text

Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers by Noguchi, Masanori, Stamey, Thomas A, McNeal, John E, Nolley, Rosalie

“…We evaluated secondary cancers in the prostate in relation to predictions of pathological stage and prognosis. A total of 222 men with T1c (impalpable)…”
Get more information

Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical Prostatectomy by PATEL, Deep A, PRESTI, Joseph C, MCNEAL, John E, GILL, Harcharan, BROOKS, James D, KING, Christopher R

“…Preoperative prostate-specific antigen (PSA) velocity (PSAV), or the rate of PSA rise before diagnosis, predicts for risk of cancer death after radical…”
Get full text

Patterns of spread of adenocarcinoma in the prostate as related to cancer volume by McNeal, John E., Haillot, Olivier

“…BACKGROUND Peripheral zone (PZ) and transition zone (TZ) cancers of the prostate remain confined to their zone of origin under 4 cc volume, with progressive…”
Get full text

Vitamin D Receptor Start Codon Polymorphism (FokI) and Prostate Cancer Progression by YUE XU, SHIBATA, Atsuko, MCNEAL, John E, STAMEY, Thomas A, FELDMAN, David, PEEHL, Donna M

“…Vitamin D plays an important role in cell growth and differentiation and is proposed to protect against cancer initiation and/or progression. The vitamin D…”
Get full text

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer by Stamey, T A, Freiha, F S, McNeal, J E, Redwine, E A, Whittemore, A S, Schmid, H P

“…Using the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute and American total mortality rates, the authors calculated the…”
Get more information

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? by Stamey, Thomas A, Caldwell, Mitchell, McNeal, John E, Nolley, Rosalie, Hemenez, Marci, Downs, Joshua

“…We assessed how well preoperative serum prostate specific antigen (PSA) reflects the largest cancer in consecutive untreated radical prostatectomies during the…”
Get more information

Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? by Cohen, Ronald J, Shannon, Beverley A, McNeal, John E, Shannon, Tom, Garrett, Kerryn L

“…Inflammation is commonly observed in the prostate gland and has been implicated in the development of prostate cancer. The etiology of prostatic inflammation…”
Get more information

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate by Stamey, T A, Yang, N, Hay, A R, McNeal, J E, Freiha, F S, Redwine, E

“…To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we measured them by…”
Get more information

Reduced 1α-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition by HSU, Ju-Yu, FELDMAN, David, MCNEAL, John E, PEEHL, Donna M

Get full text

Dynamic Regulation of Estrogen Receptor-β Expression by DNA Methylation During Prostate Cancer Development and Metastasis by Zhu, Xuegong, Leav, Irwin, Leung, Yuet-kin, Wu, Mengchu, Liu, Qin, Gao, Ying, McNeal, John E., Ho, Shuk-Mei

“…Estrogen receptor ( ER )-β is thought to exert anti-proliferative effects in the normal prostate but supports prostate cancer (PCa) cell survival. We…”
Get full text

Biological Determinants of Cancer Progression in Men With Prostate Cancer by Stamey, Thomas A, McNeal, John E, Yemoto, Cheryl M, Sigal, Bronislava M, Johnstone, Iain M

“…CONTEXT The recent increase in ability to diagnose prostatic adenocarcinoma has created a dilemma for treatment decisions. OBJECTIVE To determine whether…”
Get full text

Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma by Leav, Irwin, Lau, Kin-Mang, Adams, Jason Y., McNeal, John E., Taplin, Mary-Ellen, Wang, Jianfu, Singh, Hema, Ho, Shuk-Mei

“…An antibody, GC-17, thoroughly characterized for its specificity for estrogen receptor-β (ER-β), was used to immunolocalize the receptor in histologically…”
Get full text

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients by King, Christopher R, McNeal, John E, Gill, Harcharan, Presti, Jr, Joseph C

“…With sextant prostate biopsies, there is up to a 1-in-3 chance that the underlying pathologic Gleason grade is higher. Knowledge of the underlying grade might…”
Get more information

Application of tissue-marking ink to prostate biopsy specimens by Terris, Martha K., McNeal, John E.

“…BACKGROUND When sextant prostate biopsy specimens are performed, noting the location from which cancer‐containing cores were taken aids in treatment planning…”
Get full text

Adenoid cystic/basal cell carcinoma of the prostate: Clinicopathologic findings in 19 cases by ICZKOWSKI, Kenneth A, FERGUSON, Kevin L, GRIER, David D, HOSSAIN, Deloar, BANERJEE, S. S, MCNEAL, John E, BOSTWICK, David G

“…Adenoid cystic/basal cell carcinoma (ACBCC) of the prostate has been considered to have indolent biologic potential. However, outcome data are scant, with only…”
Get full text

Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml by Stamey, Thomas A, Johnstone, Iain M, McNeal, John E, Lu, Arthur Y, Yemoto, Cheryl M

“…Serum prostate specific antigen (PSA) is widely used as a guide to initiate prostatic biopsies and to follow men older than 50 years old with and without…”
Get more information

Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer by Chen, Zuxiong, Fan, Zhenbin, McNeal, John E, Nolley, Rosalie, Caldwell, Mitchell C, Mahadevappa, Mamatha, Zhang, Zhaomei, Warrington, Janet A, Stamey, Thomas A

“…Recent studies have shown that hepsin, a serine protease, is over expressed in prostate cancers, implicating hepsin activity in tumor invasion. Using…”
Get more information

Use of extended systematic sampling in patients with a prior negative prostate needle biopsy by Chon, Chris H, Lai, Frank C, McNeal, John E, Presti, Jr, Joseph C

“…We examine the potential impact of extended systematic biopsy schemes in patients with a prior negative prostate biopsy. Between January 1999 and March 2001,…”
Get more information

Assessment of morphometric measurements of prostate carcinoma volume by Noguchi, Masanori, Stamey, Thomas A., McNeal, John E., Yemoto, Cheryl E. M.

“…BACKGROUND The authors have shown that the primary determinants of prostate carcinoma progression are tumor volume and the percent of the tumor comprised of…”
Get full text